Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
CALL
Global Ship Lease
GSL
$1.52B
| $13.1M | ﹤0.01% |
795,100
+438,800
| +123% | +$9.67M |
|
2252
PUT
ChargePoint
CHPT
$160M
| $13.1M | ﹤0.01% |
47,910
+6,020
| +14% | +$1.67M |
|
2253
CALL
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.21B
| $13.1M | ﹤0.01% |
381,900
+67,900
| +22% | +$3.69M |
|
2254
Energizer
ENR
$1.56B
| $13.1M | ﹤0.01% |
462,468
-19,719
| -4% | -$593K |
|
2255
PUT
Oneok
OKE
$59.9B
| $13.1M | ﹤0.01% |
235,900
+105,500
| +81% | +$6.84M |
|
2256
CALL
Global X Lithium & Battery Tech ETF
LIT
$1.61B
| $13.1M | ﹤0.01% |
180,200
+13,000
| +8% | +$924K |
|
2257
CALL
Zillow
ZG
$7.91B
| $13.1M | ﹤0.01% |
411,300
+24,800
| +6% | +$979K |
|
2258
Magnite
MGNI
$3.55B
| $13.1M | ﹤0.01% |
1,472,401
+441,022
| +43% | +$4.73M |
|
|
BNY
2259
PUT
Bank of New York Mellon
BNY
$111B
| $13.1M | ﹤0.01% |
313,300
+88,400
| +39% | +$3.94M |
|
2260
CALL
Carlisle Companies
CSL
$14.7B
| $13.1M | ﹤0.01% |
54,700
+48,100
| +729% | +$12M |
|
2261
Graco
GGG
$13.3B
| $13M | ﹤0.01% |
+219,587
| New | +$13.8M |
|
2262
Clean Harbors
CLH
$17B
| $13M | ﹤0.01% |
148,610
+76,888
| +107% | +$7.42M |
|
2263
GH Research
GHRS
$2.02B
| $13M | ﹤0.01% |
1,303,470
+27,738
| +2% | +$361K |
|
2264
Moderna
MRNA
$25.3B
| $13M | ﹤0.01% |
90,959
+70,149
| +337% | +$10M |
|
2265
CALL
FMC
FMC
$1.27B
| $13M | ﹤0.01% |
121,400
+16,200
| +15% | +$1.98M |
|
2266
PUT
NovoCure
NVCR
$1.97B
| $13M | ﹤0.01% |
186,900
+31,400
| +20% | +$2.37M |
|
2267
ATI
ATI
$31.1B
| $13M | ﹤0.01% |
571,504
+36,650
| +7% | +$966K |
|
2268
State Street Financial Select Sector SPDR ETF
XLF
$59.4B
| $13M | ﹤0.01% |
412,534
+229,257
| +125% | +$7.92M |
|
|
LAC
2269
CALL
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $13M | ﹤0.01% |
644,500
-215,000
| -25% | -$5.5M |
|
2270
AngloGold Ashanti
AU
$48.7B
| $13M | ﹤0.01% |
876,891
+632,257
| +258% | +$12M |
|
|
BKI
2271
CALL
DELISTED
Black Knight, Inc. Common Stock
BKI
| $13M | ﹤0.01% |
198,100
+177,900
| +881% | +$12M |
|
2272
CALL
Guardant Health
GH
$21.1B
| $12.9M | ﹤0.01% |
320,900
+66,100
| +26% | +$3.28M |
|
|
JWN
2273
CALL
DELISTED
Nordstrom
JWN
| $12.9M | ﹤0.01% |
611,800
-172,300
| -22% | -$4.4M |
|
2274
Global E Online
GLBE
$7.12B
| $12.9M | ﹤0.01% |
638,876
+572,430
| +861% | +$13.1M |
|
2275
CALL
Canadian Imperial Bank of Commerce
CM
$113B
| $12.9M | ﹤0.01% |
265,200
+57,200
| +28% | +$3.11M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.